Glofitamab in combination with CD19 CAR-T therapy for high-risk relapsed/refractory large B-cell lymphoma
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Rong Shen, Ling-Shuang Sheng, Zi-Xun Yan, Yu-Yue Liang, Wen Wu, Li Wang, Wei Li Zhao
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417006004